デジタル PCR / デジタル PCR (dPCR) ＆リアルタイム PCR (qPCR) 市場 : 2029年までの世界予測

Report Overview

The global digital PCR (dPCR) and real-time PCR (qPCR) market is projected to reach USD 14.8 billion by 2029 from USD 10.0 billion in 2024, at a CAGR of 8.1% during the forecast period of 2024 to 2029. The growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market has been significantly driven by its increasing adoption among hospital and diagnostics laboratories for disease diagnosis application, increasing R&D investment by key players for the development and launch of innovative product and continuous advancements in PCR technologies. However, high instrument costs especially that of dPCR and the technical limitations of PCR are restraining market growth.

“The infectious disease testing segment under clinical application segment accounted for the largest share by application in 2023.”
In 2023, the infectious disease testing segment under clinical application segment accounted for the largest share by application in the global digital PCR (dPCR) and real-time PCR (qPCR) market. qPCR has revolutionized infectious disease diagnostics by providing rapid, sensitive, and specific detection of pathogens. It is useful in identifying bacteria, viruses, fungi, and parasites, enabling early diagnosis and effective treatment. During the past decade, clinical laboratories worldwide have been increasing using qPCR for pathogen testing and the diagnosis of infectious and sexually transmitted diseases. Advanced molecular diagnosis tools such as spectroscopy and liquid chromatography are being integrated with qPCR workflows to offer genomic lab technicians the capability of rapid and accurate pathogen detection.

“The US has continued to dominate the digital PCR (dPCR) and real-time PCR (qPCR) market during the forecast period of 2024-2029.”
The US is the world’s largest biopharmaceutical market and a leader in biopharmaceutical research/investments. The demand for digital PCR (dPCR) and real-time PCR (qPCR) products is expected to grow in the coming years, driven by the rising patient population suffering from infectious disease, increasing focus on biopharmaceuticals, and the need for safe & high-quality products in the healthcare industry. The nation has a highly advanced market in terms of R&D due to the presence of better infrastructure, government support, and private funding. This helps develop innovative and advanced technologies for research. Pharmaceutical companies in the US are actively participating in the development of novel reagent and test assays and utilizing it with Digital PCR (dPCR) and real-time PCR (qPCR), which offers less turnaround time, and is energy-efficient also provide accurate results, with in a span of time. These factors are supporting the growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market in the country.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
• By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

List of Companies Profiled in the Report:

Danaher Corporation (US)
F. Hoffmann-La Roche Ltd (Switzerland)
Thermo Fisher Scientific Inc. (US)
Merck KGaA (Germany)
Qiagen N.V. (Germany)
Abbott Laboratories (US)
Biomerieux (France)
Becton, Dickinson and Company (US)
Agilent Technologies, Inc. (US)
Eppendorf AG (Germany)
Bio-Rad Laboratories, Inc. (US)
Takara Bio Inc. (Japan)
Promega Corporation (US)
Meridian Bioscience, Inc. (US)
ENDRESS+HAUSER (Switzerland)
QuidelOrtho Corporation (US)
Lepu Medical Technology Beijing Co Ltd. (China)
Sysmax Corporation (Japan)
Enzo Biochem, Inc. (US)
Biocartis (Belgium)
Stilla Technologies (France)
Antylia Scientific (US)
Bioneer Corporation (South Korea)
Standard BioTools (US)
Seegene Inc. (South Korea)
GenScript (US)
LGC Bioresearch Technologies (England)
Quantabio (US)
Randox Laboratories Ltd. (UK)
New England Biolabs. (US)
PCR Biosystems (UK)

Research Coverage:
This research report categorizes the digital PCR (dPCR) and real-time PCR (qPCR) market by offering ((QPCR product (QPCR Reagents and Consumables, QPCR Instruments), QPCR Software, and QPCR Services) DPCR Product (QPCR Reagents and Consumables, QPCR Instruments (Droplet Digital PCR, Chip Based Digital PCR, and Beaming Digital PCR), DPCR Software, and DPCR Services)), by applications ((QPCR Application (Clinical Application (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, and Other Clinical Application), Research Application (Single Cell Analysis, Stem Cell Research, Gene Expression, and Other Research Application), Forensic Application, Environmental Applications, and Other Application), and (DPCR Application (Clinical Application (Infectious Disease Testing, Oncology Testing, Blood Screening, Transplant Diagnostics, and Other Clinical Application), Research Application (Single Cell Analysis, Stem Cell Research, Gene Expression, and Other Research Application), Forensic Application, Environmental Applications, and Other Application)), by end user ((QPCR End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories, and Others), and (DPCR End User (Hospitals and Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, CROs and CDMOs, Forensic Laboratories, and Others)) and by region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Digital PCR (dPCR) and real-time PCR (qPCR) market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, solutions, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the Digital PCR (dPCR) and real-time PCR (qPCR) market.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall digital PCR (dPCR) and real-time PCR (qPCR) market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:
• Analysis of key drivers (Rising incidence and prevalence of target infectious diseases and genetic disorders, Continuous advancements in PCR technologies, The role of PCR in biomarker discovery, Increased use of dPCR and qPCR technologies for point of care (POC) diagnostics), restraints (High device costs associated with dPCR, Technical limitations of qPCR and dPCR, Unfavorable reimbursement scenario for diagnostic companies), opportunities (Growing market penetration in emerging countries, Integration of qPCR and dPCR with Next-Generation Sequencing (NGS), Growing significance of RT-PCR based companion diagnostics in drug development process), and Challenges (Time Consuming methodology involving in sample handling and post-PCR analysis, Lack of accuracy & standardization in protocol, Availability of alternative technologies for disease diagnosis) influencing the growth of the market).
• Product Development/Innovation: Detailed insights on newly launched products of the digital PCR (dPCR) and real-time PCR (qPCR) market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the digital PCR (dPCR) and real-time PCR (qPCR) market
• Competitive Assessment: Danaher Corporation (US), F. Hoffmann-La Roche Ltd (Switzerland), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Qiagen N.V. (Germany), Abbott Laboratories (US), Biomerieux (France), Becton, Dickinson and Company (US), Agilent Technologies, Inc. (US), Eppendorf AG (Germany), Bio-Rad Laboratories, Inc. (US), Takara Bio Inc. (Japan), among others in the market.

Table of Contents

1            INTRODUCTION            82

1.1         STUDY OBJECTIVES      82

1.2         MARKET DEFINITION   82

1.2.1      INCLUSIONS & EXCLUSIONS     83

1.3         MARKETS COVERED     84

1.3.1      MARKET SEGMENTATION         84

1.3.2      REGIONS COVERED      85

FIGURE 1           REGIONAL SEGMENTATION     85

1.3.3      YEARS CONSIDERED     85

1.3.4      CURRENCY CONSIDERED          86

1.4         STAKEHOLDERS            86

1.5         SUMMARY OF CHANGES            86

1.5.1      RECESSION IMPACT      87

2            RESEARCH METHODOLOGY     88

2.1         RESEARCH APPROACH 88

FIGURE 2           RESEARCH DESIGN METHODOLOGY    88

2.1.1      SECONDARY RESEARCH             89

2.1.2      PRIMARY RESEARCH     89

FIGURE 3           DPCR AND QPCR MARKET: BREAKDOWN OF PRIMARIES              90

2.2         MARKET SIZE ESTIMATION       91

FIGURE 4           DIGITAL PCR (DPCR) AND QUANTITATIVE PCR (QPCR) MARKET SIZE ESTIMATION  (SUPPLY-SIDE ANALYSIS), 2023     91

2.2.1      GLOBAL MARKET ESTIMATION 91

FIGURE 5           MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023             92

FIGURE 6           ILLUSTRATIVE EXAMPLE OF QIAGEN N.V.: REVENUE SHARE ANALYSIS (2023)            92

2.2.2      INSIGHTS OF PRIMARY EXPERTS            94

FIGURE 7           MARKET SIZE VALIDATION FROM PRIMARY SOURCES  94

2.2.3      SEGMENTAL MARKET SIZE ESTIMATION           95

FIGURE 8           MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH       95

2.3         GROWTH RATE PROJECTIONS  96

FIGURE 9           DPCR AND QPCR MARKET: CAGR PROJECTIONS, 2024–2029              96

TABLE 1             IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS           97

2.4         MARKET BREAKDOWN AND DATA TRIANGULATION    97

FIGURE 10         DATA TRIANGULATION METHODOLOGY         98

2.5         STUDY ASSUMPTIONS  98

2.6         RISK ASSESSMENT         99

TABLE 2             RISK ASSESSMENT ANALYSIS    99

2.7         RESEARCH LIMITATIONS           99

2.8         RECESSION IMPACT ANALYSIS 99

3            EXECUTIVE SUMMARY 101

FIGURE 11         QPCR MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)              101

FIGURE 12         DPCR MARKET, BY OFFERING, 2024 VS. 2029 (USD MILLION)              102

FIGURE 13         QPCR MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)              103

FIGURE 14         DPCR MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)              103

FIGURE 15         QPCR MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)              104

FIGURE 16         DPCR MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)              104

FIGURE 17         GEOGRAPHIC SNAPSHOT OF DPCR AND QPCR MARKET              105

4            PREMIUM INSIGHTS      106

4.1         DIGITAL PCR (DPCR) AND QUANTITATIVE/REAL-TIME PCR (QPCR) MARKET OVERVIEW     106

FIGURE 18         RISING INCIDENCE OF INFECTIOUS DISEASES AND GENETIC DISORDERS TO DRIVE MARKET DURING FORECAST PERIOD    106

4.2         ASIA PACIFIC: QPCR MARKET, BY OFFERING AND COUNTRY (2024)              107

FIGURE 19         QPCR PRODUCTS SEGMENT IN CHINA TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024          107

4.3         GEOGRAPHIC SNAPSHOT OF DPCR AND QPCR MARKET            108

FIGURE 20         EMERGING MARKETS TO GROW AT HIGHER GROWTH RATE DURING FORECAST PERIOD     108

5            MARKET OVERVIEW     109

5.1         INTRODUCTION            109

5.2         MARKET DYNAMICS     109

FIGURE 21         DPCR AND QPCR MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES 109

TABLE 3             DPCR AND QPCR MARKET: IMPACT ANALYSIS  110

5.2.1      DRIVERS            111

5.2.1.1   Rising incidence of infectious diseases and genetic disorders      111

TABLE 4             GLOBAL BURDEN OF HIV INFECTIONS, BY REGION (2022)              111

5.2.1.2   Increasing advancements in PCR technologies             112

TABLE 5             CONVENTIONAL PCR VS. QPCR & DPCR             113

5.2.1.3   Increasing applications of PCR in biomarker discovery 113

5.2.1.4   Growing focus on dPCR and qPCR technologies for POC diagnostics      114

5.2.2      RESTRAINTS     114

5.2.2.1   High cost of dPCR instruments        114

5.2.2.2   Technical limitations associated with qPCR and dPCR 115

5.2.2.3   Unfavorable reimbursements for diagnostic companies 115

5.2.3      OPPORTUNITIES           116

5.2.3.1   High growth potential of emerging markets   116

5.2.3.2   Integration of qPCR and dPCR with NGS      116

5.2.3.3   Growing significance of RT-PCR-based companion diagnostics in drug development        117

5.2.4      CHALLENGES   117

5.2.4.1   Time constraints associated with sample handling        117

5.2.4.2   Inadequate protocols for accuracy & standardization    118

5.2.4.3   Availability of alternative technologies           118

5.3         PORTER’S FIVE FORCES ANALYSIS         119

FIGURE 22         DPCR AND QPCR MARKET: PORTER’S FIVE FORCES ANALYSIS              119

TABLE 6             DPCR AND QPCR MARKET: PORTER’S FIVE FORCES ANALYSIS              119

5.3.1      DEGREE OF COMPETITION       120

5.3.2      BARGAINING POWER OF SUPPLIERS     120

5.3.3      BARGAINING POWER OF BUYERS           120

5.3.4      THREAT OF SUBSTITUTES         120

5.3.5      THREAT OF NEW ENTRANTS    120

5.4         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 121

FIGURE 23         DPCR AND QPCR MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 121

5.5         TECHNOLOGY ANALYSIS           122

5.5.1      KEY TECHNOLOGIES    122

TABLE 7             KEY TECHNOLOGIES    122

5.5.2      COMPLEMENTARY TECHNOLOGIES     123

TABLE 8             COMPLEMENTARY TECHNOLOGIES     123

5.5.3      ADJACENT TECHNOLOGIES      124

TABLE 9             ADJACENT TECHNOLOGIES      124

5.6         SUPPLY CHAIN ANALYSIS          124

FIGURE 24         SUPPLY CHAIN ANALYSIS          124

5.7         VALUE CHAIN ANALYSIS            125

FIGURE 25         VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING RAW MATERIAL PROCUREMENT AND MANUFACTURING STAGES         126

5.8         PRICING ANALYSIS        127

TABLE 10           AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT (2023)   127

FIGURE 26         AVERAGE SELLING PRICE TREND FOR QPCR INSTRUMENTS (2021−2023)      128

TABLE 11           AVERAGE SELLING PRICE, BY PRODUCT, BY REGION (2023)              129

5.9         ECOSYSTEM ANALYSIS 129

FIGURE 27         DPCR AND QPCR MARKET: ECOSYSTEM ANALYSIS        129

5.9.1      DPCR AND QPCR MARKET: ROLE OF RAW MATERIAL SUPPLIERS              130

TABLE 12           DPCR AND QPCR MARKET: RAW MATERIAL SUPPLIERS 130

5.9.2      DPCR AND QPCR MARKET: ROLE OF MANUFACTURERS             130

TABLE 13           DPCR AND QPCR MARKET: ROLE OF MANUFACTURERS              131

5.9.3      DPCR AND QPCR MARKET: ROLE OF END USERS            131

TABLE 14           DPCR AND QPCR MARKET: ROLE OF END USERS            132

5.9.4      DPCR AND QPCR MARKET: ROLE OF REGULATORY BODIES      132

TABLE 15           DPCR AND QPCR MARKET: ROLE OF REGULATORY BODIES              132

5.10       PATENT ANALYSIS        133

5.10.1    PATENT METHODOLOGY         133

5.10.2    PATENTS FILED, BY DOCUMENT TYPE, 2014–2024          133

TABLE 16           PATENTS FILED, 2014–2024        133

5.10.3    INNOVATION & PATENT APPLICATIONS           133

FIGURE 28         NUMBER OF PATENTS GRANTED, 2014–2024      133

5.10.4    TOP APPLICANTS          134

FIGURE 29         TOP TEN PATENT APPLICANTS, 2014–2024        134

TABLE 17           TOP 20 PATENT OWNERS IN QPCR AND DPCR MARKET, 2014–2024      134

5.11       KEY CONFERENCES AND EVENTS (2024−2025) 135

TABLE 18           DPCR AND QPCR MARKET: LIST OF CONFERENCES AND EVENTS (2024−2025)    135

5.12       REGULATORY LANDSCAPE       136

5.12.1    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          136

TABLE 19           LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 136

5.12.2    REGULATORY SCENARIO           138

5.13       KEY STAKEHOLDERS AND BUYING CRITERIA    141

5.13.1    KEY STAKEHOLDERS IN BUYING PROCESS         141

FIGURE 30         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR DPCR & QPCR PRODUCTS         141

5.13.2    KEY BUYING CRITERIA AMONG END USERS       142

FIGURE 31         KEY BUYING CRITERIA FOR END USERS              142

TABLE 20           BUYING CRITERIA FOR DPCR AND QPCR PRODUCTS, BY END USER    142

5.14       INVESTMENT & FUNDING SCENARIO    143

5.15       TRADE ANALYSIS          144

TABLE 21           IMPORT VALUE, BY COUNTRY, 2019–2023 (USD THOUSANDS)              144

TABLE 22           EXPORT VALUE, BY COUNTRY, 2019–2023 (USD THOUSAND)              145

TABLE 23           IMPORT VOLUME, BY COUNTRY, 2019–2023 (TONS)       145

TABLE 24           EXPORT VOLUME, BY COUNTRY, 2019–2023 (TONS)       146

6            DPCR AND QPCR MARKET, BY OFFERING          147

6.1         INTRODUCTION            148

TABLE 25           DPCR AND QPCR MARKET, BY OFFERING, 2022–2029 (USD MILLION)          148

6.2         QPCR OFFERINGS          148

TABLE 26           QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)              148

TABLE 27           QPCR OFFERING MARKET, BY REGION, 2022–2029 (USD MILLION)          149

TABLE 28           NORTH AMERICA: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          149

TABLE 29           EUROPE: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149

TABLE 30           ASIA PACIFIC: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     150

TABLE 31           LATIN AMERICA: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          150

TABLE 32           MIDDLE EAST: QPCR OFFERINGS MARKET, BY REGION, 2022–2029 (USD MILLION)     150

TABLE 33           GCC COUNTRIES: QPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          151

6.2.1      QPCR PRODUCTS          151

TABLE 34           QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          151

6.2.1.1   qPCR reagents & consumables        151

6.2.1.1.1 Recurring consumption of detection agents to drive market       151

TABLE 35           QPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)          152

TABLE 36           NORTH AMERICA: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      152

TABLE 37           EUROPE: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 153

TABLE 38           ASIA PACIFIC: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 153

TABLE 39           LATIN AMERICA: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)         154

TABLE 40           MIDDLE EAST: QPCR REAGENTS & CONSUMABLES MARKET, BY REGION,  2022–2029 (USD MILLION)             154

TABLE 41          GCC COUNTRIES: QPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            154

TABLE 42           QPCR REAGENTS & CONSUMABLES MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        155

TABLE 43           QPCR REAGENTS & CONSUMABLES MARKET, BY END USER, 2022–2029 (USD MILLION)          155

6.2.1.2   qPCR instruments             156

6.2.1.2.1 Advancements in instrument design to drive market    156

TABLE 44           INSTALLED BASE FOR QPCR INSTRUMENTS, BY PRODUCT, 2019−2023         156

TABLE 45           QPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)          156

TABLE 46           NORTH AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 157

TABLE 47           EUROPE: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     157

TABLE 48           ASIA PACIFIC: QPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          157

TABLE 49          LATIN AMERICA: QPCR INSTRUMENTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)          158

TABLE 50           MIDDLE EAST: QPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)          158

TABLE 51           GCC COUNTRIES: QPCR INSTRUMENTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 158

TABLE 52           QPCR INSTRUMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 159

TABLE 53           QPCR INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)          159

6.2.2      QPCR SOFTWARE          160

6.2.2.1   Rising demand for specialized analysis software to support market growth              160

TABLE 54           QPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)          160

TABLE 55           NORTH AMERICA: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          160

TABLE 56           EUROPE: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161

TABLE 57           ASIA PACIFIC: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     161

TABLE 58           LATIN AMERICA: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          161

TABLE 59           MIDDLE EAST: QPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)     162

TABLE 60           GCC COUNTRIES: QPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          162

TABLE 61           QPCR SOFTWARE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          162

TABLE 62           QPCR SOFTWARE MARKET, BY END USER, 2022–2029 (USD MILLION)          163

6.2.3      QPCR SERVICES             163

6.2.3.1   Growing requirement for maintenance and calibration of PCR instruments to fuel market   163

TABLE 63           QPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          164

TABLE 64           NORTH AMERICA: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          164

TABLE 65           EUROPE: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164

TABLE 66           ASIA PACIFIC: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     165

TABLE 67           LATIN AMERICA: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          165

TABLE 68           MIDDLE EAST: QPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)     165

TABLE 69           GCC COUNTRIES: QPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          166

TABLE 70           QPCR SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          166

TABLE 71           QPCR SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)          166

6.3         DPCR OFFERINGS          167

TABLE 72           DPCR OFFERINGS MARKET, BY TYPE, 2022–2029 (USD MILLION)          167

TABLE 73           DPCR OFFERINGS MARKET, BY REGION, 2022–2029 (USD MILLION)          167

TABLE 74           NORTH AMERICA: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          168

TABLE 75           EUROPE: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168

TABLE 76           ASIA PACIFIC: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     168

TABLE 77           LATIN AMERICA: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          169

TABLE 78           MIDDLE EAST: DPCR OFFERINGS MARKET, BY REGION, 2022–2029 (USD MILLION)     169

TABLE 79           GCC COUNTRIES: DPCR OFFERINGS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          169

6.3.1      DPCR PRODUCTS          170

TABLE 80           DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          170

6.3.1.1   DPCR reagents & consumables       170

6.3.1.1.1 Availability of novel dPCR reagents to propel market   170

TABLE 81           DPCR REAGENTS & CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)          171

TABLE 82           NORTH AMERICA: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)      171

TABLE 83           EUROPE: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 171

TABLE 84           ASIA PACIFIC: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 172

TABLE 85           LATIN AMERICA: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)         172

TABLE 86           MIDDLE EAST: DPCR REAGENTS & CONSUMABLES MARKET, BY REGION,  2022–2029 (USD MILLION)             172

TABLE 87          GCC COUNTRIES: DPCR REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)            173

TABLE 88          DPCR REAGENTS & CONSUMABLES MARKET, BY APPLICATION,  2022–2029 (USD MILLION)          173

TABLE 89           DPCR REAGENTS & CONSUMABLES MARKET, BY END USER, 2022–2029 (USD MILLION)          174

6.3.1.2   DPCR instruments            174

TABLE 90           DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          174

TABLE 91           DPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)          175

TABLE 92           NORTH AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 175

TABLE 93           EUROPE: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     175

TABLE 94           ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          176

TABLE 95          LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)          176

TABLE 96           MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)          176

TABLE 97           GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 177

TABLE 98           DPCR INSTRUMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 177

TABLE 99           DPCR INSTRUMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)          178

6.3.1.2.1 Droplet digital PCR           178

6.3.1.2.1.1           High accuracy and time efficiency benefits to fuel uptake           178

TABLE 100         DROPLET DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)          178

TABLE 101         NORTH AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 179

TABLE 102         EUROPE: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          179

TABLE 103         ASIA PACIFIC: DROPLET DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          179

TABLE 104         LATIN AMERICA: DROPLET DIGITAL PCR MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 180

TABLE 105         MIDDLE EAST: DROPLET DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)          180

TABLE 106         GCC COUNTRIES: DROPLET DIGITAL PCR MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 180

6.3.1.2.2 Chip-based digital PCR     181

6.3.1.2.2.1           High-throughput capabilities to boost demand             181

TABLE 107         CHIP-BASED DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION) 181

TABLE 108         NORTH AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 181

TABLE 109         EUROPE: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          182

TABLE 110         ASIA PACIFIC: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 182

TABLE 111         LATIN AMERICA: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 183

TABLE 112         MIDDLE EAST: CHIP-BASED DIGITAL PCR MARKET, BY REGION,  2022–2029 (USD MILLION)     183

TABLE 113         GCC COUNTRIES: CHIP-BASED DIGITAL PCR MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 183

6.3.1.2.3 Beaming digital PCR         184

6.3.1.2.3.1           Growing applications in oncology diagnostics to support market growth              184

TABLE 114         BEAMING DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)          184

TABLE 115         NORTH AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 184

TABLE 116         EUROPE: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          185

TABLE 117         ASIA PACIFIC: BEAMING DIGITAL PCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          185

TABLE 118         LATIN AMERICA: BEAMING DIGITAL PCR MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 185

TABLE 119         MIDDLE EAST: BEAMING DIGITAL PCR MARKET, BY REGION, 2022–2029 (USD MILLION)          186

TABLE 120         GCC COUNTRIES: BEAMING DIGITAL PCR MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 186

6.3.2      DPCR SOFTWARE          186

6.3.2.1   Ability to enhance workflow efficiency to drive market 186

TABLE 121         DPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)          187

TABLE 122         NORTH AMERICA: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          187

TABLE 123         EUROPE: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 187

TABLE 124         ASIA PACIFIC: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     188

TABLE 125         LATIN AMERICA: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          188

TABLE 126         MIDDLE EAST: DPCR SOFTWARE MARKET, BY REGION, 2022–2029 (USD MILLION)     188

TABLE 127         GCC COUNTRIES: DPCR SOFTWARE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          189

TABLE 128         DPCR SOFTWARE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          189

TABLE 129         DPCR SOFTWARE MARKET, BY END USER, 2022–2029 (USD MILLION)          190

6.3.3      DPCR SERVICES             190

6.3.3.1   Rising need for application-specific guidance to support market growth   190

TABLE 130         DPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)          191

TABLE 131         NORTH AMERICA: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          191

TABLE 132         EUROPE: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191

TABLE 133         ASIA PACIFIC: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     192

TABLE 134         LATIN AMERICA: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          192

TABLE 135         MIDDLE EAST: DPCR SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)     192

TABLE 136         GCC COUNTRIES: DPCR SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          193

TABLE 137         DPCR SERVICES MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          193

TABLE 138         DPCR SERVICES MARKET, BY END USER, 2022–2029 (USD MILLION)          194

7            DPCR AND QPCR MARKET, BY APPLICATION    195

7.1         INTRODUCTION            196

TABLE 139         QPCR AND DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          196

7.2         QPCR APPLICATIONS   196

TABLE 140         APPLICATION EXAMPLES OF QPCR       196

TABLE 141         QPCR APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)          197

7.2.1      CLINICAL APPLICATIONS          197

TABLE 142         QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)     198

TABLE 143         QPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)          198

TABLE 144         NORTH AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           199

TABLE 145         EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION) 199

TABLE 146         ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)         200

TABLE 147         LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        200

TABLE 148         MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)             201

TABLE 149         GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        201

7.2.1.1   Infectious disease testing    201

7.2.1.1.1 Wide utilization in pathogen testing to fuel market      201

TABLE 150         QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION,  2022–2029 (USD MILLION)     202

TABLE 151         NORTH AMERICA: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)        202

TABLE 152         EUROPE: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY,  2022–2029 (USD MILLION)         203

TABLE 153         ASIA PACIFIC: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY,  2022–2029 (USD MILLION)     203

TABLE 154         LATIN AMERICA: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY,  2022–2029 (USD MILLION)     204

TABLE 155         MIDDLE EAST: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION,  2022–2029 (USD MILLION)         204

TABLE 156         GCC COUNTRIES: QPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)        204

7.2.1.2   Oncology testing  205

7.2.1.2.1 High uptake in tumor screening & classification to boost demand            205

TABLE 157         QPCR MARKET FOR ONCOLOGY TESTING, BY REGION,  2022–2029 (USD MILLION)     205

TABLE 158         NORTH AMERICA: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY,  2022–2029 (USD MILLION)         205

TABLE 159         EUROPE: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY,  2022–2029 (USD MILLION) 206

TABLE 160         ASIA PACIFIC: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY,  2022–2029 (USD MILLION) 206

TABLE 161         LATIN AMERICA: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY,  2022–2029 (USD MILLION)         207

TABLE 162         MIDDLE EAST: QPCR MARKET FOR ONCOLOGY TESTING, BY REGION,  2022–2029 (USD MILLION)     207

TABLE 163         GCC COUNTRIES: QPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY,  2022–2029 (USD MILLION)         207

7.2.1.3   Blood screening   208

7.2.1.3.1 Elimination of post-amplification processing to drive market     208

TABLE 164         QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION,  2022–2029 (USD MILLION)    208

TABLE 165         NORTH AMERICA: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY,  2022–2029 (USD MILLION) 208

TABLE 166         EUROPE: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY,  2022–2029 (USD MILLION) 209

TABLE 167         ASIA PACIFIC: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY,  2022–2029 (USD MILLION) 209

TABLE 168         LATIN AMERICA: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY,  2022–2029 (USD MILLION) 210

TABLE 169         MIDDLE EAST: QPCR MARKET FOR BLOOD SCREENING, BY REGION,  2022–2029 (USD MILLION)     210

TABLE 170         GCC COUNTRIES: QPCR MARKET FOR BLOOD SCREENING, BY COUNTRY,  2022–2029 (USD MILLION) 210

7.2.1.4   Transplant diagnostics       211

7.2.1.4.1 Growing preference for genome-based products to fuel market  211

TABLE 171         QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION,  2022–2029 (USD MILLION) 211

TABLE 172         NORTH AMERICA: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)             211

TABLE 173         EUROPE: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY,  2022–2029 (USD MILLION) 212

TABLE 174         ASIA PACIFIC: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY,  2022–2029 (USD MILLION)          212

TABLE 175         LATIN AMERICA: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)             213

TABLE 176         MIDDLE EAST: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION,  2022–2029 (USD MILLION) 213

TABLE 177         GCC COUNTRIES: QPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)             213

7.2.1.5   Other clinical applications 214

TABLE 178         QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)     214

TABLE 179         NORTH AMERICA: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           214

TABLE 180         EUROPE: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        215

TABLE 181         ASIA PACIFIC: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        215

TABLE 182         LATIN AMERICA: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           216

TABLE 183         MIDDLE EAST: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)            216

TABLE 184         GCC COUNTRIES: QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           216

7.2.2      RESEARCH APPLICATIONS        217

TABLE 185         QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)     217

TABLE 186         QPCR MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)          217

TABLE 187         NORTH AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        218

TABLE 188         EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION) 218

TABLE 189         ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)         219

TABLE 190         LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        219

TABLE 191         MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)             219

TABLE 192         GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        220

7.2.2.1   Single-cell analysis             220

7.2.2.1.1 Growing need for high-resolution molecular data to drive market            220

TABLE 193         QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022–2029 (USD MILLION)     220

TABLE 194        NORTH AMERICA: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY,  2022–2029 (USD MILLION)         221

TABLE 195         EUROPE: QPCR MARKET FOR SINGLE-CELL ANALYSIS, 2022–2029 (USD MILLION)     221

TABLE 196         ASIA PACIFIC: QPCR MARKET FOR SINGLE-CELL ANALYSIS, 2022–2029 (USD MILLION)          221

TABLE 197         LATIN AMERICA: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY,  2022–2029 (USD MILLION)         222

TABLE 198         MIDDLE EAST: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION,  2022–2029 (USD MILLION)     222

TABLE 199         GCC COUNTRIES: QPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY,  2022–2029 (USD MILLION)         222

7.2.2.2   Stem cell research 223

7.2.2.2.1 Growing focus on regenerative medicine to boost demand         223

TABLE 200         QPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)     223

TABLE 201         NORTH AMERICA: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY,  2022–2029 (USD MILLION)         223

TABLE 202         EUROPE: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY,  2022–2029 (USD MILLION) 224

TABLE 203         ASIA PACIFIC: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY,  2022–2029 (USD MILLION) 224

TABLE 204         LATIN AMERICA: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY,  2022–2029 (USD MILLION)         225

TABLE 205         MIDDLE EAST: QPCR MARKET FOR STEM CELL RESEARCH, BY REGION,  2022–2029 (USD MILLION)     225

TABLE 206         GCC COUNTRIES: QPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY,  2022–2029 (USD MILLION)         225

7.2.2.3   Gene expression  226

7.2.2.3.1 Precise quantification requirements to support market growth   226

TABLE 207         QPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022–2029 (USD MILLION) 226

TABLE 208         NORTH AMERICA: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY,  2022–2029 (USD MILLION) 226

TABLE 209         EUROPE: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY,  2022–2029 (USD MILLION) 227

TABLE 210         ASIA PACIFIC: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY,  2022–2029 (USD MILLION) 227

TABLE 211         LATIN AMERICA: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY,  2022–2029 (USD MILLION) 228

TABLE 212         MIDDLE EAST: QPCR MARKET FOR GENE EXPRESSION, BY REGION,  2022–2029 (USD MILLION)     228

TABLE 213         GCC COUNTRIES: QPCR MARKET FOR GENE EXPRESSION, BY COUNTRY,  2022–2029 (USD MILLION) 228

7.2.2.4   Other research applications             229

TABLE 214         QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)     229

TABLE 215         NORTH AMERICA: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           230

TABLE 216         EUROPE: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           230

TABLE 217         ASIA PACIFIC: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           231

TABLE 218         LATIN AMERICA: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           231

TABLE 219         MIDDLE EAST: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)            231

TABLE 220         GCC COUNTRIES: QPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           232

7.2.3      FORENSIC APPLICATIONS         232

7.2.3.1   Ability to analyze genetic fingerprinting and biological samples to propel market              232

TABLE 221         QPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)          232

TABLE 222         NORTH AMERICA: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        233

TABLE 223         EUROPE: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION) 233

TABLE 224         ASIA PACIFIC: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)         234

TABLE 225         LATIN AMERICA: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        234

TABLE 226         MIDDLE EAST: QPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)             234

TABLE 227         GCC COUNTRIES: QPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        235

7.2.4      ENVIRONMENTAL APPLICATIONS         235

7.2.4.1   Development of specialized assays for environmental monitoring to drive market              235

TABLE 228         QPCR ENVIRONMENTAL APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION)          235

TABLE 229         NORTH AMERICA: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           236

TABLE 230         EUROPE: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        236

TABLE 231         ASIA PACIFIC: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        237

TABLE 232         LATIN AMERICA: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           237

TABLE 233         MIDDLE EAST: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)            237

TABLE 234         GCC COUNTRIES: QPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           238

7.2.5      OTHER QPCR APPLICATIONS   238

TABLE 235         OTHER QPCR APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 238

TABLE 236         NORTH AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 239

TABLE 237        EUROPE: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)          239

TABLE 238         ASIA PACIFIC: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 240

TABLE 239         LATIN AMERICA: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 240

TABLE 240         MIDDLE EAST: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 240

TABLE 241         GCC COUNTRIES: OTHER QPCR APPLICATIONS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 241

7.3         DPCR APPLICATIONS   241

TABLE 242         DPCR APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION)          241

7.3.1      CLINICAL APPLICATIONS          242

TABLE 243         DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)     242

TABLE 244         DPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)          242

TABLE 245         NORTH AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        243

TABLE 246         EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION) 243

TABLE 247         ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)         244

TABLE 248         LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        244

TABLE 249         MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)             244

TABLE 250         GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           245

7.3.1.1   Infectious disease testing    245

7.3.1.1.1 Accuracy and precision capabilities to boost demand   245

TABLE 251         DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION,  2022–2029 (USD MILLION)     245

TABLE 252         NORTH AMERICA: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)        246

TABLE 253         EUROPE: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY,  2022–2029 (USD MILLION)         246

TABLE 254         ASIA PACIFIC: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY,  2022–2029 (USD MILLION)     247

TABLE 255         LATIN AMERICA: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY,  2022–2029 (USD MILLION)     247

TABLE 256         MIDDLE EAST: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY REGION,  2022–2029 (USD MILLION)         247

TABLE 257         GCC COUNTRIES: DPCR MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2022–2029 (USD MILLION)        248

7.3.1.2   Oncology testing  248

7.3.1.2.1 Detection and monitoring of cancer-related genetic alterations to drive market              248

TABLE 258         DPCR MARKET FOR ONCOLOGY TESTING, BY REGION, 2022–2029 (USD MILLION)     249

TABLE 259         NORTH AMERICA: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY,  2022–2029 (USD MILLION)         249

TABLE 260         EUROPE: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY,  2022–2029 (USD MILLION) 249

TABLE 261         ASIA PACIFIC: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY,  2022–2029 (USD MILLION) 250

TABLE 262         LATIN AMERICA: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY,  2022–2029 (USD MILLION) 250

TABLE 263         MIDDLE EAST: DPCR MARKET FOR ONCOLOGY TESTING, BY REGION,  2022–2029 (USD MILLION)     250

TABLE 264         GCC COUNTRIES: DPCR MARKET FOR ONCOLOGY TESTING, BY COUNTRY,  2022–2029 (USD MILLION)         251

7.3.1.3   Blood screening   251

7.3.1.3.1 Highly sensitive detection of infectious agents to support market growth 251

TABLE 265         DPCR MARKET FOR BLOOD SCREENING, BY REGION, 2022–2029 (USD MILLION)     251

TABLE 266         NORTH AMERICA: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY,  2022–2029 (USD MILLION) 252

TABLE 267         EUROPE: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY,  2022–2029 (USD MILLION) 252

TABLE 268         ASIA PACIFIC: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY,  2022–2029 (USD MILLION) 253

TABLE 269         LATIN AMERICA: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY,  2022–2029 (USD MILLION) 253

TABLE 270         MIDDLE EAST: DPCR MARKET FOR BLOOD SCREENING, BY REGION,  2022–2029 (USD MILLION)     253

TABLE 271         GCC COUNTRIES: DPCR MARKET FOR BLOOD SCREENING, BY COUNTRY,  2022–2029 (USD MILLION) 254

7.3.1.4   Transplant diagnostics       254

7.3.1.4.1 Low market availability to restrain market      254

TABLE 272         DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)          254

TABLE 273         NORTH AMERICA: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY,  2022–2029 (USD MILLION)          255

TABLE 274         EUROPE: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY,  2022–2029 (USD MILLION) 255

TABLE 275         ASIA PACIFIC: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY,  2022–2029 (USD MILLION)          256

TABLE 276         LATIN AMERICA: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY,  2022–2029 (USD MILLION)          256

TABLE 277         MIDDLE EAST: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY REGION,  2022–2029 (USD MILLION) 256

TABLE 278         GCC COUNTRIES: DPCR MARKET FOR TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)             257

7.3.1.5   Other clinical applications 257

TABLE 279         DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)       257

TABLE 280         NORTH AMERICA: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           258

TABLE 281         EUROPE: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        258

TABLE 282         ASIA PACIFIC: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        259

TABLE 283         LATIN AMERICA: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           259

TABLE 284         MIDDLE EAST: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)            259

TABLE 285         GCC COUNTRIES: DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           260

7.3.2      RESEARCH APPLICATIONS        260

7.3.2.1   High uptake by pharma & biotech companies for drug screening to drive market              260

TABLE 286         DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)     260

7.3.2.2   Single-cell analysis             261

7.3.2.2.1 dDPCR compatibility with one-step RT-PCR to boost demand  261

TABLE 287         DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2022–2029 (USD MILLION)     261

TABLE 288        NORTH AMERICA: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY,  2022–2029 (USD MILLION)         262

TABLE 289         EUROPE: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY,  2022–2029 (USD MILLION) 262

TABLE 290         ASIA PACIFIC: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY,  2022–2029 (USD MILLION) 263

TABLE 291         LATIN AMERICA: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY,  2022–2029 (USD MILLION)         263

TABLE 292         MIDDLE EAST: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY REGION,  2022–2029 (USD MILLION)     263

TABLE 293         GCC COUNTRIES: DPCR MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY,  2022–2029 (USD MILLION)         264

7.3.2.3   Stem cell research 264

7.3.2.3.1 Growing need for reliable tools to assess stem cell quality & potency to boost demand 264

TABLE 294         DPCR MARKET FOR STEM CELL RESEARCH, BY REGION, 2022–2029 (USD MILLION)     264

TABLE 295         NORTH AMERICA: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY,  2022–2029 (USD MILLION)         265

TABLE 296         EUROPE: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY,  2022–2029 (USD MILLION) 265

TABLE 297         ASIA PACIFIC: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY,  2022–2029 (USD MILLION) 266

TABLE 298         LATIN AMERICA: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY,  2022–2029 (USD MILLION)         266

TABLE 299         MIDDLE EAST: DPCR MARKET FOR STEM CELL RESEARCH, BY REGION,  2022–2029 (USD MILLION)     267

TABLE 300         GCC COUNTRIES: DPCR MARKET FOR STEM CELL RESEARCH, BY COUNTRY,  2022–2029 (USD MILLION)         267

7.3.2.4   Gene expression  267

7.3.2.4.1 Increasing demand for accurate quantification methods in personalized medicine to drive market    267

TABLE 301         DPCR MARKET FOR GENE EXPRESSION, BY REGION, 2022–2029 (USD MILLION) 268

TABLE 302         NORTH AMERICA: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY,  2022–2029 (USD MILLION) 268

TABLE 303         EUROPE: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY,  2022–2029 (USD MILLION) 269

TABLE 304         ASIA PACIFIC: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY,  2022–2029 (USD MILLION) 269

TABLE 305         LATIN AMERICA: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY,  2022–2029 (USD MILLION) 270

TABLE 306         MIDDLE EAST: DPCR MARKET FOR GENE EXPRESSION, BY REGION,  2022–2029 (USD MILLION)     270

TABLE 307         GCC COUNTRIES: DPCR MARKET FOR GENE EXPRESSION, BY COUNTRY,  2022–2029 (USD MILLION) 270

7.3.2.5   Other research applications             271

TABLE 308         DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)     271

TABLE 309         NORTH AMERICA: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           272

TABLE 310         EUROPE: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        272

TABLE 311         ASIA PACIFIC: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           273

TABLE 312         LATIN AMERICA: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           273

TABLE 313         MIDDLE EAST: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)            273

TABLE 314         GCC COUNTRIES: DPCR MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           274

7.3.3      FORENSIC APPLICATIONS         274

7.3.3.1   DNA profiling benefits to support market growth        274

TABLE 315         DPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)          275

TABLE 316         NORTH AMERICA: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        275

TABLE 317         EUROPE: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION) 275

TABLE 318         ASIA PACIFIC: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)         276

TABLE 319         LATIN AMERICA: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        276

TABLE 320         MIDDLE EAST: DPCR MARKET FOR FORENSIC APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)             276

TABLE 321         GCC COUNTRIES: DPCR MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        277

7.3.4      ENVIRONMENTAL APPLICATIONS         277

7.3.4.1   Increasing demand for wastewater surveillance to drive market  277

TABLE 322         DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)     277

TABLE 323         NORTH AMERICA: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           278

TABLE 324         EUROPE: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        278

TABLE 325         ASIA PACIFIC: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY,  2022–2029 (USD MILLION)        279

TABLE 326         LATIN AMERICA: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           279

TABLE 327         MIDDLE EAST: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)            279

TABLE 328         GCC COUNTRIES: DPCR MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)           280

7.3.5      OTHER DPCR APPLICATIONS   280

TABLE 329         OTHER DPCR APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 280

TABLE 330         NORTH AMERICA: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 281

TABLE 331        EUROPE: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)          281

TABLE 332         ASIA PACIFIC: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 282

TABLE 333         LATIN AMERICA: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 282

TABLE 334         MIDDLE EAST: OTHER DPCR APPLICATIONS MARKET, BY REGION,  2022–2029 (USD MILLION)     282

TABLE 335         GCC COUNTRIES: OTHER DPCR APPLICATIONS MARKET, BY COUNTRY,  2022–2029 (USD MILLION) 283

8            DPCR AND QPCR MARKET, BY END USER           284

8.1         INTRODUCTION            285

TABLE 336         DPCR AND QPCR MARKET FOR END USERS, BY TECHNOLOGY,  2022–2029 (USD MILLION)          285

8.2         QPCR END USERS          285

TABLE 337         QPCR MARKET FOR END USERS, BY TYPE, 2022–2029 (USD MILLION)          285

8.2.1      HOSPITALS AND DIAGNOSTIC LABORATORIES 286

8.2.1.1   Growing uptake in disease diagnostics to drive market 286

TABLE 338         QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION,  2022–2029 (USD MILLION)           286

TABLE 339         NORTH AMERICA: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES,  BY COUNTRY, 2022–2029 (USD MILLION)              286

TABLE 340         EUROPE: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)          287

TABLE 341         ASIA PACIFIC: QPCR FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)          287

TABLE 342         LATIN AMERICA: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES,  BY COUNTRY, 2022–2029 (USD MILLION)              288

TABLE 343         MIDDLE EAST: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES,  BY REGION, 2022–2029 (USD MILLION) 288

TABLE 344         GCC COUNTRIES: QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES,  BY COUNTRY, 2022–2029 (USD MILLION)              288

8.2.2      ACADEMIC & RESEARCH INSTITUTES   289

8.2.2.1   Growing focus on genetic & molecular studies to boost demand 289

TABLE 345         QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION,  2022–2029 (USD MILLION)     289

TABLE 346         NORTH AMERICA: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)          289

TABLE 347         EUROPE: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,  2022–2029 (USD MILLION) 290

TABLE 348        ASIA PACIFIC: QPCR FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY,  2022–2029 (USD MILLION)         290

TABLE 349         LATIN AMERICA: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)  291

TABLE 350         MIDDLE EAST: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)      291

TABLE 351         GCC COUNTRIES: QPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)  291

8.2.3      PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES   292

8.2.3.1   Rising focus on drug discovery & development to propel market 292

TABLE 352         QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)      292

TABLE 353         NORTH AMERICA: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              292

TABLE 354         EUROPE: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,  BY COUNTRY, 2022–2029 (USD MILLION)              293

TABLE 355         ASIA PACIFIC: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              293

TABLE 356         LATIN AMERICA: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              294

TABLE 357         MIDDLE EAST: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 294

TABLE 358         GCC COUNTRIES: QPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              294

8.2.4      CROS AND CDMOS        295

8.2.4.1   Increasing outsourcing of drug development activities by pharma companies to boost demand      295

TABLE 359         QPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022–2029 (USD MILLION) 295

TABLE 360         NORTH AMERICA: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY,  2022–2029 (USD MILLION) 295

TABLE 361        EUROPE: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY,  2022–2029 (USD MILLION)          296

TABLE 362         ASIA PACIFIC: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY,  2022–2029 (USD MILLION) 296

TABLE 363         LATIN AMERICA: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY,  2022–2029 (USD MILLION) 297

TABLE 364         MIDDLE EAST: QPCR MARKET FOR CROS AND CDMOS, BY REGION,  2022–2029 (USD MILLION)     297

TABLE 365         GCC COUNTRIES: QPCR MARKET FOR CROS AND CDMOS, BY COUNTRY,  2022–2029 (USD MILLION) 297

8.2.5      FORENSIC LABORATORIES        298

8.2.5.1   Growing trend of laboratory automation to drive market            298

TABLE 366         QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)          298

TABLE 367         NORTH AMERICA: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY,  2022–2029 (USD MILLION)       298

TABLE 368         EUROPE: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY,  2022–2029 (USD MILLION) 299

TABLE 369         ASIA PACIFIC: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY,  2022–2029 (USD MILLION)         299

TABLE 370         LATIN AMERICA: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY,  2022–2029 (USD MILLION)       300

TABLE 371         MIDDLE EAST: QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION,  2022–2029 (USD MILLION)             300

TABLE 372         GCC COUNTRIES: QPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY,  2022–2029 (USD MILLION)       300

8.2.6      OTHER END USERS        301

TABLE 373         QPCR MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 301

TABLE 374         NORTH AMERICA: QPCR MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD MILLION) 301

TABLE 375         EUROPE: QPCR MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD MILLION) 302

TABLE 376         ASIA PACIFIC: QPCR MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD MILLION) 302

TABLE 377         LATIN AMERICA: QPCR MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD MILLION) 303

TABLE 378         MIDDLE EAST: QPCR MARKET FOR OTHER END USERS, BY REGION,  2022–2029 (USD MILLION)     303

TABLE 379         GCC COUNTRIES: QPCR MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD MILLION) 303

8.3         DPCR END USERS          304

TABLE 380         DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)              304

8.3.1      HOSPITALS AND DIAGNOSTIC LABORATORIES 304

8.3.1.1   High uptake in genetic testing and embryo DNA profiling to drive market              304

TABLE 381         DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY REGION,  2022–2029 (USD MILLION)           305

TABLE 382         NORTH AMERICA: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES,  BY COUNTRY, 2022–2029 (USD MILLION)              305

TABLE 383         EUROPE: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES,  2022–2029 (USD MILLION)     305

TABLE 384         ASIA PACIFIC: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES,  BY COUNTRY, 2022–2029 (USD MILLION)              306

TABLE 385         LATIN AMERICA: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES,  BY COUNTRY, 2022–2029 (USD MILLION)              306

TABLE 386         MIDDLE EAST: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES,  BY REGION, 2022–2029 (USD MILLION) 306

TABLE 387         GCC COUNTRIES: DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC LABORATORIES,  BY COUNTRY, 2022–2029 (USD MILLION)              307

8.3.2      ACADEMIC & RESEARCH INSTITUTES   307

8.3.2.1   Rising R&D funding investments to support market growth       307

TABLE 388         DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION,  2022–2029 (USD MILLION)     307

TABLE 389         NORTH AMERICA: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)          308

TABLE 390         EUROPE: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES,  2022–2029 (USD MILLION)           308

TABLE 391         ASIA PACIFIC: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)  309

TABLE 392         LATIN AMERICA: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)  309

TABLE 393         MIDDLE EAST: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)      309

TABLE 394         GCC COUNTRIES: DPCR MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)  310

8.3.3      PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES   310

8.3.3.1   High uptake in toxicity & clinical studies to drive market           310

TABLE 395         DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)      311

TABLE 396         NORTH AMERICA: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              311

TABLE 397         EUROPE: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,  BY COUNTRY, 2022–2029 (USD MILLION)              311

TABLE 398         ASIA PACIFIC: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              312

TABLE 399         LATIN AMERICA: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              312

TABLE 400         MIDDLE EAST: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 312

TABLE 401         GCC COUNTRIES: DPCR MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)              313

8.3.4      CROS AND CDMOS        313

8.3.4.1   Rising number of clinical trials to support market growth           313

TABLE 402         DPCR MARKET FOR CROS AND CDMOS, BY REGION, 2022–2029 (USD MILLION) 313

TABLE 403         NORTH AMERICA: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY,  2022–2029 (USD MILLION) 314

TABLE 404        EUROPE: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY,  2022–2029 (USD MILLION)          314

TABLE 405         ASIA PACIFIC: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY,  2022–2029 (USD MILLION) 315

TABLE 406         LATIN AMERICA: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY,  2022–2029 (USD MILLION) 315

TABLE 407         MIDDLE EAST: DPCR MARKET FOR CROS AND CDMOS, BY REGION,  2022–2029 (USD MILLION)     315

TABLE 408         GCC COUNTRIES: DPCR MARKET FOR CROS AND CDMOS, BY COUNTRY,  2022–2029 (USD MILLION) 316

8.3.5      FORENSIC LABORATORIES        316

8.3.5.1   Development of advanced dPCR assays to support market growth           316

TABLE 409         DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)          316

TABLE 410         NORTH AMERICA: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY,  2022–2029 (USD MILLION)       317

TABLE 411         EUROPE: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY,  2022–2029 (USD MILLION) 317

TABLE 412         ASIA PACIFIC: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY,  2022–2029 (USD MILLION)         318

TABLE 413         LATIN AMERICA: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY,  2022–2029 (USD MILLION)       318

TABLE 414         MIDDLE EAST: DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION,  2022–2029 (USD MILLION)             318

TABLE 415         GCC COUNTRIES: DPCR MARKET FOR FORENSIC LABORATORIES, BY COUNTRY,  2022–2029 (USD MILLION)       319

8.3.6      OTHER END USERS        319

TABLE 416         DPCR MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 319

TABLE 417         NORTH AMERICA: DPCR MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD MILLION) 320

TABLE 418         EUROPE: DPCR MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD MILLION) 320

TABLE 419         ASIA PACIFIC: DPCR MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD MILLION) 321

TABLE 420         LATIN AMERICA: DPCR MARKET FOR OTHER END USERS, BY COUNTRY,  2022–2029 (USD MILLION) 321

TABLE 421         MIDDLE EAST: DPCR MARKET FOR OTHER END USERS, BY REGION,  2022–2029 (USD MILLION)     321

TABLE 422         GCC COUNTRIES: DPCR MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)    322

9            DPCR AND QPCR MARKET, BY REGION 323

9.1         INTRODUCTION            324

TABLE 423         DPCR AND QPCR MARKET, BY REGION, 2022–2029 (USD MILLION)          324

9.2         NORTH AMERICA          324

9.2.1      NORTH AMERICA: RECESSION IMPACT 325

FIGURE 32         NORTH AMERICA: DPCR AND QPCR MARKET SNAPSHOT              326

TABLE 424         NORTH AMERICA: DPCR AND QPCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          326

TABLE 425         NORTH AMERICA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          327

TABLE 426         NORTH AMERICA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)     327

TABLE 427         NORTH AMERICA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     327

TABLE 428         NORTH AMERICA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)     328

TABLE 429         NORTH AMERICA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     328

TABLE 430         NORTH AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          328

TABLE 431         NORTH AMERICA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 329

TABLE 432         NORTH AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   329

TABLE 433         NORTH AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   330

TABLE 434         NORTH AMERICA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 330

TABLE 435         NORTH AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   331

TABLE 436         NORTH AMERICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   331

TABLE 437         NORTH AMERICA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION) 332

TABLE 438         NORTH AMERICA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION) 332

9.2.2      US         333

9.2.2.1   Rising adoption of advanced technologies to drive market          333

TABLE 439         US: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 333

TABLE 440         US: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          333

TABLE 441         US: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          334

TABLE 442         US: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          334

TABLE 443         US: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          334

TABLE 444         US: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          335

TABLE 445         US: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          335

TABLE 446         US: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          335

TABLE 447         US: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          336

TABLE 448         US: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          336

TABLE 449         US: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          336

TABLE 450         US: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          337

TABLE 451         US: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)              337

TABLE 452         US: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)              338

9.2.3      CANADA            338

9.2.3.1   Supportive government initiatives for genomics research to drive market 338

TABLE 453         CANADA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)     339

TABLE 454         CANADA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          339

TABLE 455         CANADA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          339

TABLE 456         CANADA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          340

TABLE 457         CANADA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          340

TABLE 458         CANADA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 340

TABLE 459         CANADA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          341

TABLE 460         CANADA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          341

TABLE 461         CANADA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          342

TABLE 462         CANADA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          342

TABLE 463         CANADA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          343

TABLE 464         CANADA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          343

TABLE 465         CANADA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          344

TABLE 466         CANADA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          344

9.3         EUROPE             345

9.3.1      EUROPE: RECESSION IMPACT   345

TABLE 467         EUROPE: QPCR AND DPCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 346

TABLE 468         EUROPE: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)     346

TABLE 469         EUROPE: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          346

TABLE 470         EUROPE: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          347

TABLE 471         EUROPE: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          347

TABLE 472         EUROPE: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          347

TABLE 473         EUROPE: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 348

TABLE 474         EUROPE: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          348

TABLE 475         EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          349

TABLE 476         EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          349

TABLE 477         EUROPE: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          350

TABLE 478         EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          350

TABLE 479         EUROPE: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          351

TABLE 480         EUROPE: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          351

TABLE 481         EUROPE: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          352

9.3.2      GERMANY         352

9.3.2.1   Rising healthcare expenditure and favorable reimbursements for diagnostic procedures to boost demand            352

TABLE 482         GERMANY: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          353

TABLE 483         GERMANY: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION) 353

TABLE 484         GERMANY: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 353

TABLE 485         GERMANY: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION) 354

TABLE 486         GERMANY: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 354

TABLE 487         GERMANY: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 354

TABLE 488         GERMANY: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          355

TABLE 489         GERMANY: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          355

TABLE 490         GERMANY: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          356

TABLE 491         GERMANY: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          356

TABLE 492         GERMANY: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          357

TABLE 493         GERMANY: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          357

TABLE 494         GERMANY: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          358

TABLE 495         GERMANY: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          358

9.3.3      UK         359

9.3.3.1   Growing focus on genomics research to drive market   359

TABLE 496         UK: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 359

TABLE 497         UK: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          359

TABLE 498         UK: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          360

TABLE 499         UK: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          360

TABLE 500         UK: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          360

TABLE 501         UK: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          361

TABLE 502         UK: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          361

TABLE 503         UK: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          361

TABLE 504         UK: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          362

TABLE 505         UK: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          362

TABLE 506         UK: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          362

TABLE 507         UK: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          363

TABLE 508         UK: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)              363

TABLE 509         UK: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)              364

9.3.4      FRANCE             364

9.3.4.1   Supportive government regulations for diagnostic assay procedures to drive market   364

TABLE 510         FRANCE: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)     364

TABLE 511         FRANCE: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          365

TABLE 512         FRANCE: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          365

TABLE 513         FRANCE: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          365

TABLE 514         FRANCE: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          366

TABLE 515         FRANCE: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 366

TABLE 516         FRANCE: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          366

TABLE 517         FRANCE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          367

TABLE 518         FRANCE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          367

TABLE 519         FRANCE: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          368

TABLE 520         FRANCE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          368

TABLE 521         FRANCE: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          369

TABLE 522         FRANCE: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          369

TABLE 523         FRANCE: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          370

9.3.5      ITALY   370

9.3.5.1   Increasing funding investments for development of innovative therapies to fuel market   370

TABLE 524         ITALY: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)     371

TABLE 525         ITALY: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          371

TABLE 526         ITALY: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          371

TABLE 527         ITALY: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          372

TABLE 528         ITALY: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          372

TABLE 529         ITALY: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 372

TABLE 530         ITALY: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          373

TABLE 531         ITALY: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          373

TABLE 532         ITALY: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          374

TABLE 533         ITALY: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          374

TABLE 534         ITALY: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          375

TABLE 535         ITALY: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          375

TABLE 536         ITALY: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          376

TABLE 537         ITALY: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          376

9.3.6      SPAIN   377

9.3.6.1   Rising funding investments for R&D to support market growth 377

TABLE 538         SPAIN: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)     377

TABLE 539         SPAIN: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          377

TABLE 540         SPAIN: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          378

TABLE 541         SPAIN: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          378

TABLE 542         SPAIN: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          378

TABLE 543         SPAIN: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 379

TABLE 544         SPAIN: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          379

TABLE 545         SPAIN: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          380

TABLE 546         SPAIN: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          380

TABLE 547         SPAIN: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          381

TABLE 548         SPAIN: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          381

TABLE 549         SPAIN: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          382

TABLE 550         SPAIN: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          382

TABLE 551         SPAIN: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          383

9.3.7      REST OF EUROPE           383

TABLE 552         REST OF EUROPE: DPCR AND QPCR MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)       383

TABLE 553         REST OF EUROPE: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)     384

TABLE 554         REST OF EUROPE: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     384

TABLE 555         REST OF EUROPE: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)     384

TABLE 556         REST OF EUROPE: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     385

TABLE 557         REST OF EUROPE: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          385

TABLE 558         REST OF EUROPE: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 385

TABLE 559         REST OF EUROPE: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   386

TABLE 560         REST OF EUROPE: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   386

TABLE 561         REST OF EUROPE: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 387

TABLE 562         REST OF EUROPE: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   387

TABLE 563         REST OF EUROPE: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   388

TABLE 564         REST OF EUROPE: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION) 388

TABLE 565         REST OF EUROPE: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION) 389

9.4         ASIA PACIFIC    389

9.4.1      ASIA PACIFIC: RECESSION IMPACT        389

FIGURE 33         ASIA PACIFIC: DPCR & QPCR MARKET SNAPSHOT          390

TABLE 566         ASIA PACIFIC: QPCR AND DPCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)     391

TABLE 567         ASIA PACIFIC: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          391

TABLE 568         ASIA PACIFIC: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION) 391

TABLE 569         ASIA PACIFIC: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 392

TABLE 570         ASIA PACIFIC: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION) 392

TABLE 571         ASIA PACIFIC: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 392

TABLE 572         ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     393

TABLE 573         ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 393

TABLE 574         ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)    393

TABLE 575         ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)    394

TABLE 576         ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 394

TABLE 577         ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)    395

TABLE 578         ASIA PACIFIC: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)    395

TABLE 579         ASIA PACIFIC: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          396

TABLE 580         ASIA PACIFIC: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          396

9.4.2      CHINA  397

9.4.2.1   Modernization of healthcare infrastructure to propel market      397

TABLE 581         CHINA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)     398

TABLE 582         CHINA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          398

TABLE 583         CHINA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          398

TABLE 584         CHINA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          399

TABLE 585         CHINA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          399

TABLE 586         CHINA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 399

TABLE 587         CHINA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          400

TABLE 588         CHINA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          400

TABLE 589         CHINA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          401

TABLE 590         CHINA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          401

TABLE 591        CHINA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          402

TABLE 592         CHINA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          402

TABLE 593         CHINA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          403

TABLE 594         CHINA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          403

9.4.3      JAPAN  404

9.4.3.1   Rising number of oncology research activities to drive market    404

TABLE 595         JAPAN: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)     404

TABLE 596         JAPAN: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          405

TABLE 597         JAPAN: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          405

TABLE 598         JAPAN: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          405

TABLE 599         JAPAN: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          406

TABLE 600         JAPAN: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 406

TABLE 601         JAPAN: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          406

TABLE 602        JAPAN: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          407

TABLE 603         JAPAN: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          407

TABLE 604         JAPAN: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          408

TABLE 605        JAPAN: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          408

TABLE 606         JAPAN: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          409

TABLE 607         JAPAN: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          409

TABLE 608         JAPAN: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          410

9.4.4      INDIA   410

9.4.4.1   Growth in pharmaceutical industry to drive market      410

TABLE 609         INDIA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 411

TABLE 610         INDIA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          411

TABLE 611         INDIA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          411

TABLE 612         INDIA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          411

TABLE 613         INDIA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          412

TABLE 614         INDIA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 412

TABLE 615         INDIA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          412

TABLE 616         INDIA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          413

TABLE 617         INDIA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          413

TABLE 618         INDIA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          414

TABLE 619         INDIA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)          414

TABLE 620         INDIA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          415

TABLE 621         INDIA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          415

TABLE 622         INDIA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          416

9.4.5      AUSTRALIA       416

9.4.5.1   Growth in biopharmaceuticals market sector to fuel market       416

TABLE 623         AUSTRALIA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          416

TABLE 624         AUSTRALIA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION) 417

TABLE 625         AUSTRALIA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 417

TABLE 626         AUSTRALIA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION) 417

TABLE 627         AUSTRALIA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 418

TABLE 628         AUSTRALIA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     418

TABLE 629         AUSTRALIA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          418

TABLE 630         AUSTRALIA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          419

TABLE 631         AUSTRALIA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)    419

TABLE 632         AUSTRALIA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          419

TABLE 633         AUSTRALIA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          420

TABLE 634         AUSTRALIA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)    420

TABLE 635         AUSTRALIA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          421

TABLE 636         AUSTRALIA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          421

9.4.6      SOUTH KOREA 422

9.4.6.1   Development of advanced PCR-based diagnostic instruments to support market growth   422

TABLE 637         SOUTH KOREA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          422

TABLE 638         SOUTH KOREA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION) 422

TABLE 639         SOUTH KOREA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     423

TABLE 640         SOUTH KOREA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION) 423

TABLE 641         SOUTH KOREA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     423

TABLE 642         SOUTH KOREA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     424

TABLE 643         SOUTH KOREA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 424

TABLE 644         SOUTH KOREA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)       424

TABLE 645        SOUTH KOREA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)    425

TABLE 646         SOUTH KOREA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 425

TABLE 647         SOUTH KOREA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)    426

TABLE 648        SOUTH KOREA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)    426

TABLE 649         SOUTH KOREA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          427

TABLE 650         SOUTH KOREA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          427

9.4.7      REST OF ASIA PACIFIC  428

TABLE 651         REST OF ASIA PACIFIC: DPCR AND QPCR MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)       428

TABLE 652         REST OF ASIA PACIFIC: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          428

TABLE 653         REST OF ASIA PACIFIC: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          428

TABLE 654         REST OF ASIA PACIFIC: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          429

TABLE 655         REST OF ASIA PACIFIC: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          429

TABLE 656         REST OF ASIA PACIFIC: DPCR INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          429

TABLE 657         REST OF ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     430

TABLE 658         REST OF ASIA PACIFIC: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      430

TABLE 659         REST OF ASIA PACIFIC: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   431

TABLE 660         REST OF ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     431

TABLE 661         REST OF ASIA PACIFIC: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   432

TABLE 662         REST OF ASIA PACIFIC: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   432

TABLE 663         REST OF ASIA PACIFIC: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)     433

TABLE 664         REST OF ASIA PACIFIC: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)     433

9.5         LATIN AMERICA             434

9.5.1      LATIN AMERICA: RECESSION IMPACT   434

TABLE 665         LATIN AMERICA: QPCR AND DPCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          434

TABLE 666        LATIN AMERICA: DPCR AND QPCR MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)          435

TABLE 667         LATIN AMERICA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)     435

TABLE 668         LATIN AMERICA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     435

TABLE 669         LATIN AMERICA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)     436

TABLE 670         LATIN AMERICA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     436

TABLE 671         LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          436

TABLE 672         LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 437

TABLE 673         LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   437

TABLE 674         LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   438

TABLE 675         LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 438

TABLE 676         LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   439

TABLE 677         LATIN AMERICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   439

TABLE 678         LATIN AMERICA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          440

TABLE 679         LATIN AMERICA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          440

9.5.2      BRAZIL 441

9.5.2.1   High burden of chronic and infectious diseases to propel market             441

TABLE 680         BRAZIL: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)     441

TABLE 681         BRAZIL: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          441

TABLE 682         BRAZIL: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          442

TABLE 683         BRAZIL: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          442

TABLE 684         BRAZIL: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          442

TABLE 685         BRAZIL: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 443

TABLE 686         BRAZIL: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          443

TABLE 687         BRAZIL: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          443

TABLE 688         BRAZIL: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          444

TABLE 689         BRAZIL: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          444

TABLE 690         BRAZIL: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          444

TABLE 691         BRAZIL: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          445

TABLE 692         BRAZIL: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          445

TABLE 693         BRAZIL: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          446

9.5.3      MEXICO             446

9.5.3.1   Growing availability of advanced diagnostic instruments to boost demand              446

TABLE 694         MEXICO: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)     447

TABLE 695         MEXICO: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          447

TABLE 696         MEXICO: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          447

TABLE 697         MEXICO: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          448

TABLE 698         MEXICO: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          448

TABLE 699         MEXICO: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 448

TABLE 700         MEXICO: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          449

TABLE 701         MEXICO: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          449

TABLE 702         MEXICO: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          450

TABLE 703         MEXICO: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          450

TABLE 704         MEXICO: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          451

TABLE 705         MEXICO: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          451

TABLE 706         MEXICO: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          452

TABLE 707         MEXICO: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          452

9.5.4      REST OF LATIN AMERICA          452

TABLE 708         REST OF LATIN AMERICA: DPCR AND QPCR MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)       453

TABLE 709         REST OF LATIN AMERICA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          453

TABLE 710        REST OF LATIN AMERICA: QPCR PRODUCTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          453

TABLE 711         REST OF LATIN AMERICA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          454

TABLE 712        REST OF LATIN AMERICA: DPCR PRODUCTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          454

TABLE 713         REST OF LATIN AMERICA: DPCR INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          454

TABLE 714         REST OF LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          455

TABLE 715         REST OF LATIN AMERICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      455

TABLE 716         REST OF LATIN AMERICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      456

TABLE 717         REST OF LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          456

TABLE 718         REST OF LATIN AMERICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   457

TABLE 719         REST OF LATIN AMERICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   457

TABLE 720         REST OF LATIN AMERICA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)     458

TABLE 721         REST OF LATIN AMERICA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)     458

9.6         MIDDLE EAST  459

9.6.1      MIDDLE EAST: RECESSION IMPACT       459

TABLE 722         MIDDLE EAST: DPCR AND QPCR MARKET, BY REGION, 2022–2029 (USD MILLION)     459

TABLE 723         MIDDLE EAST: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          460

TABLE 724         MIDDLE EAST: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION) 460

TABLE 725         MIDDLE EAST: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 460

TABLE 726         MIDDLE EAST: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION) 461

TABLE 727         MIDDLE EAST: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 461

TABLE 728         MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     461

TABLE 729         MIDDLE EAST: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 462

TABLE 730         MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)    462

TABLE 731         MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)    463

TABLE 732         MIDDLE EAST: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 463

TABLE 733         MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)    464

TABLE 734         MIDDLE EAST: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)    464

TABLE 735         MIDDLE EAST: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          465

TABLE 736         MIDDLE EAST: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          465

9.6.2      GCC COUNTRIES           465

TABLE 737         GCC COUNTRIES: DPCR AND QPCR MARKET, BY COUNTRY, 2022–2029 (USD MILLION)          466

TABLE 738         GCC COUNTRIES: DPCR AND QPCR MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)       466

TABLE 739         GCC COUNTRIES: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)     466

TABLE 740         GCC COUNTRIES: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     467

TABLE 741         GCC COUNTRIES: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)     467

TABLE 742         GCC COUNTRIES: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)     467

TABLE 743         GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          468

TABLE 744         GCC COUNTRIES: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 468

TABLE 745         GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   469

TABLE 746         GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   469

TABLE 747         GCC COUNTRIES: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 470

TABLE 748         GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   470

TABLE 749         GCC COUNTRIES: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      471

TABLE 750         GCC COUNTRIES: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION) 471

TABLE 751         GCC COUNTRIES: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION) 472

9.6.2.1   Kingdom of Saudi Arabia   472

9.6.2.1.1 Growing healthcare expenditure to boost market         472

TABLE 752         KINGDOM OF SAUDI ARABIA: DPCR AND QPCR MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)       473

TABLE 753         KINGDOM OF SAUDI ARABIA: QPCR OFFERING MARKET, BY TYPE,  2022–2029 (USD MILLION)          473

TABLE 754         KINGDOM OF SAUDI ARABIA: QPCR PRODUCTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          473

TABLE 755         KINGDOM OF SAUDI ARABIA: DPCR OFFERING MARKET, BY TYPE,  2022–2029 (USD MILLION)          474

TABLE 756         KINGDOM OF SAUDI ARABIA: DPCR PRODUCTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          474

TABLE 757         KINGDOM OF SAUDI ARABIA: DPCR INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION)    474

TABLE 758         KINGDOM OF SAUDI ARABIA: QPCR MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        475

TABLE 759         KINGDOM OF SAUDI ARABIA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      475

TABLE 760         KINGDOM OF SAUDI ARABIA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      476

TABLE 761         KINGDOM OF SAUDI ARABIA: DPCR MARKET, BY APPLICATION,  2022–2029 (USD MILLION)        476

TABLE 762         KINGDOM OF SAUDI ARABIA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      477

TABLE 763         KINGDOM OF SAUDI ARABIA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      477

TABLE 764         KINGDOM OF SAUDI ARABIA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          478

TABLE 765         KINGDOM OF SAUDI ARABIA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          478

9.6.2.2   United Arab Emirates        479

9.6.2.2.1 High production of biopharmaceuticals to support market growth            479

TABLE 766         UNITED ARAB EMIRATES: DPCR AND QPCR MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)       479

TABLE 767         UNITED ARAB EMIRATES: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          479

TABLE 768        UNITED ARAB EMIRATES: QPCR PRODUCTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          480

TABLE 769         UNITED ARAB EMIRATES: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          480

TABLE 770        UNITED ARAB EMIRATES: DPCR PRODUCTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          480

TABLE 771         UNITED ARAB EMIRATES: DPCR INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          481

TABLE 772         UNITED ARAB EMIRATES: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          481

TABLE 773         UNITED ARAB EMIRATES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      481

TABLE 774         UNITED ARAB EMIRATES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      482

TABLE 775         UNITED ARAB EMIRATES: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          482

TABLE 776         UNITED ARAB EMIRATES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE, 2022–2029 (USD MILLION)      483

TABLE 777         UNITED ARAB EMIRATES: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   483

TABLE 778         UNITED ARAB EMIRATES: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)     484

TABLE 779         UNITED ARAB EMIRATES: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)     484

9.6.2.3   Other GCC Countries        485

TABLE 780         OTHER GCC COUNTRIES: DPCR AND QPCR MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)       485

TABLE 781         OTHER GCC COUNTRIES: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          485

TABLE 782         OTHER GCC COUNTRIES: QPCR PRODUCTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          485

TABLE 783         OTHER GCC COUNTRIES: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          486

TABLE 784         OTHER GCC COUNTRIES: DPCR PRODUCTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          486

TABLE 785         OTHER GCC COUNTRIES: DPCR INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          486

TABLE 786         OTHER GCC COUNTRIES: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          487

TABLE 787         OTHER GCC COUNTRIES: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   487

TABLE 788         OTHER GCC COUNTRIES: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   488

TABLE 789         OTHER GCC COUNTRIES: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          488

TABLE 790         OTHER GCC COUNTRIES: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   489

TABLE 791         OTHER GCC COUNTRIES: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   489

TABLE 792         OTHER GCC COUNTRIES: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)     490

TABLE 793         OTHER GCC COUNTRIES: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)     490

9.6.3      REST OF MIDDLE EAST 491

TABLE 794         REST OF MIDDLE EAST: DPCR AND QPCR MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)       491

TABLE 795         REST OF MIDDLE EAST: QPCR OFFERING MARKET, BY TYPE,  2022–2029 (USD MILLION)          491

TABLE 796         REST OF MIDDLE EAST: QPCR PRODUCTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          491

TABLE 797         REST OF MIDDLE EAST: DPCR OFFERING MARKET, BY TYPE,  2022–2029 (USD MILLION)          492

TABLE 798         REST OF MIDDLE EAST: DPCR PRODUCTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          492

TABLE 799         REST OF MIDDLE EAST: DPCR INSTRUMENTS MARKET, BY TYPE,  2022–2029 (USD MILLION)          492

TABLE 800         REST OF MIDDLE EAST: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          493

TABLE 801         REST OF MIDDLE EAST: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   493

TABLE 802         REST OF MIDDLE EAST: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   494

TABLE 803         REST OF MIDDLE EAST: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          494

TABLE 804         REST OF MIDDLE EAST: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   495

TABLE 805         REST OF MIDDLE EAST: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)   495

TABLE 806         REST OF MIDDLE EAST: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)     496

TABLE 807         REST OF MIDDLE EAST: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)     496

9.7         AFRICA 497

9.7.1      INCREASING FOCUS ON CANCER DIAGNOSTICS TO SUPPORT MARKET GROWTH          497

9.7.2      AFRICA: RECESSION IMPACT     497

TABLE 808         AFRICA: DPCR AND QPCR MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)     497

TABLE 809         AFRICA: QPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          498

TABLE 810         AFRICA: QPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          498

TABLE 811         AFRICA: DPCR OFFERING MARKET, BY TYPE, 2022–2029 (USD MILLION)          498

TABLE 812         AFRICA: DPCR PRODUCTS MARKET, BY TYPE, 2022–2029 (USD MILLION)          499

TABLE 813         AFRICA: DPCR INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 499

TABLE 814         AFRICA: QPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          499

TABLE 815         AFRICA: QPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          500

TABLE 816         AFRICA: QPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          500

TABLE 817         AFRICA: DPCR MARKET, BY APPLICATION, 2022–2029 (USD MILLION)          501

TABLE 818         AFRICA: DPCR MARKET FOR CLINICAL APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          501

TABLE 819         AFRICA: DPCR MARKET FOR RESEARCH APPLICATIONS, BY TYPE,  2022–2029 (USD MILLION)          502

TABLE 820         AFRICA: QPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          502

TABLE 821         AFRICA: DPCR MARKET, BY END USER, 2022–2029 (USD MILLION)          503

10          COMPETITIVE LANDSCAPE       504

10.1       INTRODUCTION            504

10.2       KEY PLAYER STRATEGIES/RIGHT TO WIN          504

TABLE 822         DPCR AND QPCR MARKET: STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES             504

10.3       REVENUE ANALYSIS      505

FIGURE 34         REVENUE ANALYSIS OF KEY PLAYERS, 2019−2023 (USD MILLION)          506

10.4       MARKET SHARE ANALYSIS         506

FIGURE 35         MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)        507

TABLE 823         DPCR AND QPCR MARKET: DEGREE OF COMPETITION 507

10.5       COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023   508

10.5.1    STARS  508

10.5.2    EMERGING LEADERS    509

10.5.3    PERVASIVE PLAYERS     509

10.5.4    PARTICIPANTS 509

FIGURE 36         DPCR AND QPCR MARKET: COMPANY EVALUATION MATRIX  (KEY PLAYERS), 2023     510

10.5.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      511

10.5.5.1 Overall footprint  511

FIGURE 37         DPCR AND QPCR MARKET: OVERALL FOOTPRINT         511

10.5.5.2 Offering footprint 512

TABLE 824         DPCR AND QPCR MARKET: OFFERING FOOTPRINT       512

10.5.5.3 Application footprint         513

TABLE 825         DPCR AND QPCR MARKET: APPLICATION FOOTPRINT 513

10.5.5.4 End-user footprint             514

TABLE 826         DPCR AND QPCR MARKET: END-USER FOOTPRINT       514

10.5.5.5 Region footprint  515

TABLE 827         DPCR AND QPCR MARKET: REGION FOOTPRINT           515

10.6       COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023          517

10.6.1    PROGRESSIVE COMPANIES       517

10.6.2    RESPONSIVE COMPANIES          517

10.6.3    DYNAMIC COMPANIES 517

10.6.4    STARTING BLOCKS       517

FIGURE 38         DPCR AND QPCR MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023             518

10.6.5    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023             519

TABLE 828         DPCR AND QPCR MARKET: KEY STARTUPS/SMES          519

TABLE 829         DPCR AND QPCR MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES           520

10.7       COMPANY VALUATION & FINANCIAL METRICS 520

FIGURE 39         EV/EBITDA OF KEY DPCR AND QPCR VENDORS             520

FIGURE 40         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF  KEY DPCR AND QPCR VENDORS        521

10.8       BRAND/PRODUCT COMPARISON ANALYSIS      521

FIGURE 41         BRAND/PRODUCT COMPARISON ANALYSIS, BY DPCR AND QPCR OFFERINGS          521

10.9       COMPETITIVE SCENARIO          522

10.9.1    PRODUCT LAUNCHES & APPROVALS    522

TABLE 830         DPCR AND QPCR MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−MAY 2024 522

10.9.2    DEALS  524

TABLE 831         DPCR AND QPCR MARKET: DEALS, JANUARY 2021–MAY 2024              524

10.9.3    EXPANSIONS    526

TABLE 832         DPCR AND QPCR MARKET: EXPANSIONS, JANUARY 2021–MAY 2024      526

11          COMPANY PROFILES    527

11.1       KEY PLAYERS   527

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

11.1.1    DANAHER CORPORATION         527

TABLE 833         DANAHER CORPORATION: COMPANY OVERVIEW         527

FIGURE 42         DANAHER CORPORATION: COMPANY SNAPSHOT (2023)              528

TABLE 834         DANAHER CORPORATION: PRODUCTS OFFERED          529

TABLE 835         DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS,  JANUARY 2021–MAY 2024 531

TABLE 836         DANAHER CORPORATION: DEALS, JANUARY 2021–MAY 2024              531

11.1.2    F. HOFFMANN-LA ROCHE LTD. 533

TABLE 837         F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 533

FIGURE 43         F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)              534

TABLE 838         F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED  534

TABLE 839         F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES & APPROVALS,  JANUARY 2021–MAY 2024 536

TABLE 840         F. HOFFMANN-LA ROCHE LTD.: DEALS, JANUARY 2021–MAY 2024      537

11.1.3    THERMO FISHER SCIENTIFIC INC.          538

TABLE 841         THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW              538

FIGURE 44         THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)   539

TABLE 842         THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED              539

TABLE 843         THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS,  JANUARY 2021–MAY 2024 544

TABLE 844         THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–MAY 2024      546

11.1.4    MERCK KGAA   547

TABLE 845         MERCK KGAA: COMPANY OVERVIEW    547

FIGURE 45         MERCK KGAA: COMPANY SNAPSHOT (2023)      548

TABLE 846         MERCK KGAA: PRODUCTS OFFERED     548

11.1.5    QIAGEN N.V.     553

TABLE 847         QIAGEN N.V.: COMPANY OVERVIEW     553

FIGURE 46         QIAGEN N.V.: COMPANY SNAPSHOT (2023)        554

TABLE 848         QIAGEN N.V.: PRODUCTS OFFERED      555

TABLE 849         QIAGEN N.V.: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–MAY 2024          560

TABLE 850         QIAGEN N.V.: DEALS, JANUARY 2021–MAY 2024  561

11.1.6    BIO-RAD LABORATORIES, INC. 562

TABLE 851         BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW  562

FIGURE 47         BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)              563

TABLE 852         BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED   563

TABLE 853         BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024  565

TABLE 854         BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2021–MAY 2024      566

11.1.7    AGILENT TECHNOLOGIES, INC.             567

TABLE 855         AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 567

FIGURE 48         AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)              568

TABLE 856         AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 569

TABLE 857         AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024  571

TABLE 858         AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–MAY 2024           571

11.1.8    TAKARA BIO INC.           572

TABLE 859         TAKARA BIO INC.: COMPANY OVERVIEW           572

FIGURE 49         TAKARA BIO INC.: COMPANY SNAPSHOT (2023)             573

TABLE 860         TAKARA BIO INC.: PRODUCTS OFFERED            574

TABLE 861         TAKARA BIO INC.: DEALS, JANUARY 2021–MAY 2024       575

11.1.9    BECTON, DICKINSON, AND COMPANY 576

TABLE 862         BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW              576

FIGURE 50         BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2023)   577

TABLE 863         BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED              577

TABLE 864         BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024             578

TABLE 865         BECTON, DICKINSON AND COMPANY: DEALS, JANUARY 2021–MAY 2024           579

11.1.10  ABBOTT LABORATORIES           580

TABLE 866         ABBOTT LABORATORIES: COMPANY OVERVIEW            580

FIGURE 51         ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023) 581

11.1.10.2             Products offered  582

TABLE 867         ABBOTT LABORATORIES: PRODUCTS OFFERED            582

TABLE 868         ABBOTT LABORATORIES: PRODUCT LAUNCHES & APPROVALS,  JANUARY 2021–MAY 2024 582

11.1.11  PROMEGA CORPORATION        583

TABLE 869         PROMEGA CORPORATION: COMPANY OVERVIEW         583

TABLE 870         PROMEGA CORPORATION: PRODUCTS OFFERED          583

TABLE 871         PROMEGA CORPORATION: PRODUCT LAUNCHES & APPROVALS,  JANUARY 2021–MAY 2024 584

11.1.12  MERIDIAN BIOSCIENCE 585

TABLE 872         MERIDIAN BIOSCIENCE: COMPANY OVERVIEW 585

TABLE 873         MERIDIAN BIOSCIENCE: PRODUCTS OFFERED 586

TABLE 874         MERIDIAN BIOSCIENCE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024            587

TABLE 875         MERIDIAN BIOSCIENCE: DEALS, JANUARY 2021–MAY 2024              588

11.1.13  ENDRESS+HAUSER GROUP SERVICES AG           589

TABLE 876         ENDRESS+HAUSER GROUP SERVICES AG: COMPANY OVERVIEW        589

FIGURE 52         ENDRESS+HAUSER GROUP SERVICES AG: COMPANY SNAPSHOT (2023)          590

TABLE 877         ENDRESS+HAUSER GROUP SERVICES AG: PRODUCTS OFFERED          591

TABLE 878         ENDRESS+HAUSER GROUP SERVICES AG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024      592

TABLE 879         ENDRESS+HAUSER GROUP SERVICES AG: DEALS, JANUARY 2021–MAY 2024 592

11.1.14  BIOMÉRIEUX    593

TABLE 880         BIOMÉRIEUX: COMPANY OVERVIEW     593

FIGURE 53         BIOMÉRIEUX: COMPANY SNAPSHOT (2023)       594

TABLE 881         BIOMÉRIEUX: PRODUCTS OFFERED      595

TABLE 882         BIOMÉRIEUX: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024 595

11.1.15  EPPENDORF AG             596

TABLE 883         EPPENDORF AG: COMPANY OVERVIEW 596

FIGURE 54         EPPENDORF AG: COMPANY SNAPSHOT (2023)  597

TABLE 884         EPPENDORF AG: PRODUCTS OFFERED 597

11.1.16  QUIDELORTHO CORPORATION             598

TABLE 885         QUIDELORTHO CORPORATION: COMPANY OVERVIEW 598

FIGURE 55         QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2023)              599

TABLE 886         QUIDELORTHO CORPORATION: PRODUCTS OFFERED 599

TABLE 887         QUIDELORTHO CORPORATION: PRODUCT LAUNCHES & APPROVALS,  JANUARY 2021–MAY 2024 600

TABLE 888         QUIDELORTHO CORPORATION: DEALS, JANUARY 2021–MAY 2024      600

11.1.17  ENZO BIOCHEM INC.     601

TABLE 889         ENZO BIOCHEM INC.: COMPANY OVERVIEW     601

FIGURE 56         ENZO BIOCHEM INC.: COMPANY SNAPSHOT (2023)       601

TABLE 890         ENZO BIOCHEM INC.: PRODUCTS OFFERED      602

TABLE 891         ENZO BIOCHEM INC.: DEALS, JANUARY 2021–MAY 2024 604

11.1.18  LEPU MEDICAL TECHNOLOGY CO., LTD.           605

TABLE 892         LEPU MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW        605

FIGURE 57         LEPU MEDICAL TECHNOLOGY CO., LTD.: COMPANY SNAPSHOT (2023)          605

TABLE 893         LEPU MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED          606

11.1.19  SYSMEX CORPORATION             607

TABLE 894         SYSMEX CORPORATION: COMPANY OVERVIEW 607

FIGURE 58         SYSMEX CORPORATION: COMPANY SNAPSHOT (2023)  607

TABLE 895         SYSMEX CORPORATION: PRODUCTS OFFERED 608

11.2       STARTUP/SME PLAYERS            608

11.2.1    BIOCARTIS        608

TABLE 896         BIOCARTIS: COMPANY OVERVIEW        608

11.2.2    STILLA 609

TABLE 897         STILLA: COMPANY OVERVIEW 609

11.2.3    ANTYLIA SCIENTIFIC    610

TABLE 898         ANTYLIA SCIENTIFIC: COMPANY OVERVIEW     610

11.2.4    BIONEER CORPORATION           611

TABLE 899         BIONEER CORPORATION: COMPANY OVERVIEW           611

11.2.5    STANDARD BIOTOOLS 613

TABLE 900         STANDARD BIOTOOLS: COMPANY OVERVIEW 613

11.2.6    SEEGENE INC.   614

TABLE 901         SEEGENE INC.: COMPANY OVERVIEW   614

11.2.7    GENSCRIPT       616

TABLE 902         GENSCRIPT: COMPANY OVERVIEW       616

11.2.8    LGC BIOSEARCH TECHNOLOGIES         617

TABLE 903         LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW              617

11.2.9    QUANTABIO     619

TABLE 904         QUANTABIO: COMPANY OVERVIEW     619

11.2.10  RANDOX LABORATORIES LTD. 620

TABLE 905         RANDOX LABORATORIES LTD.: COMPANY OVERVIEW 620

11.2.11  NEW ENGLAND BIOLABS           621

TABLE 906         NEW ENGLAND BIOLABS: COMPANY OVERVIEW            621

11.2.12  PCR BIOSYSTEMS          622

TABLE 907         PCR BIOSYSTEMS: COMPANY OVERVIEW           622

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12          APPENDIX         623

12.1       DISCUSSION GUIDE      623

12.2       KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL             629

12.3       CUSTOMIZATION OPTIONS      631

12.4       RELATED REPORTS       631

12.5       AUTHOR DETAILS         632

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧